Trust Point’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$222K Buy
1,376
+138
+11% +$23K 0.02% 466
2026
Q2
$235K Buy
+1,238
New +$233K 0.02% 410

Other funds holding AZN

Trust Point's AZN Position: Q3 2026 in Review

Trust Point increased its AstraZeneca (AZN) stake by 11% in Q3 2026, buying an estimated $23K and bringing the position to 1,376 shares worth $222K. The position accounts for 0.02% of the portfolio, ranked #466.

Trust Point first reported a position in AZN in Q2 2026 and has held it in 2 quarters since. The position peaked at $235K in Q2 2026. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Trust Point held 1,376 shares of AstraZeneca worth $222K as of Q3 2026.
  • Trust Point bought 138 AstraZeneca shares in Q3 2026, an estimated $23K.
  • AstraZeneca made up 0.02% of Trust Point's portfolio in Q3 2026, its #466 holding.
  • Trust Point first reported a position in AstraZeneca in Q2 2026 and has held it in 2 quarters since.
  • Trust Point's AstraZeneca position peaked at $235K in Q2 2026.
  • 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.